InvestorsHub Logo
Followers 195
Posts 24373
Boards Moderated 0
Alias Born 04/03/2010

Re: improving post# 675732

Saturday, 03/02/2024 1:25:28 PM

Saturday, March 02, 2024 1:25:28 PM

Post# of 689027
Summary from another site. I note that the FT tweeted that article out as well.


“A group of Wall Street traders maliciously drove down the share price of a Maryland biotech with a promising new brain cancer vaccine, in pursuit of the marginal profits to be made by buying the stock cheaply and selling it back to the market.

In other words, if Citadel Securities and its ilk are to beat this case and prevent a string of copycat suits, they will probably have to give the rest of us more of a peek behind the curtain.

In a line that seemed destined to make its way on to the r/wallstreetbets message boards on Reddit, Stein further called the claims “cogent and at least as compelling as the inference that defendants were simply engaged in legitimate trading activity.”

https://beamstart.com/news/spoofing-case-might-draw-back-17093564962934

I did have a subscription to FT. But it’s not needed at the current time.

And here is another summary:

“EQUITIES

Allegations of Market Manipulation Against NWBO Spark Legal Battle
NWBO's 'spoofing' lawsuit against top broker-dealers dismissed but court sees potential for case to reveal high-speed trading practices.





?
13 hours ago
Key Takeaway

Northwest Biotherapeutics accuses Virtu and Citadel Securities of "spoofing" to lower NWBO stock, despite positive trials.
Manhattan court dismisses case against Citadel due to lack of evidence but acknowledges the plausibility of NWBO's claims.
NWBO's planned refiling could expose high-frequency trading practices, signaling a shift in handling market manipulation allegations.
Allegations of Market Manipulation

Northwest Biotherapeutics has accused seven broker-dealers, including Virtu and Citadel Securities, of engaging in "repeated spoofing" to drive down the share price of NWBO. The company alleged that these firms placed millions of sell orders they had no intention of fulfilling, leading to a significant drop in NWBO's valuation despite positive clinical trial results. The lawsuit sparked interest among Redditors, who speculated about hedge funds' motives and governance issues within NWBO.

Read more in other views:
POSITIVE
Innovative NWBO's Brain Cancer Vaccine Draws Investor Support Amid Legal Drama
NEGATIVE
Market Manipulation Allegations Cast Shadow Over Northwest Biotherapeutics' Share Price
Legal Developments

A Manhattan court recently dismissed NWBO's case against Citadel and others, citing a lack of evidence tying the alleged trading to specific losses. However, the court acknowledged the plausibility of most of NWBO's claims, suggesting that the case could proceed further. Magistrate Gary Stein found the distinction between cancelled and reduced orders unconvincing and noted the potential impact of defendants' conduct on NWBO's stock price.

Market Impact and Future Actions

NWBO plans to refile its complaint, potentially leading to the discovery process where internal records and communications from the defendants could be revealed. The outcome of this case could shed light on the practices of high-frequency trading firms and their influence on global markets. While Citadel Securities dismissed the lawsuit as malicious, the court's decision signals a shift in the default stance of market-makers regarding allegations of market manipulation.”

https://wallstreetnow.co/en/articles/2024/03/02/allegations-of-market-manipulation-against-nwbo-spark-legal-battle

Making waves…


I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News